메뉴 건너뛰기




Volumn 39, Issue 5, 2015, Pages 644-651

MYD88 (L265P) somatic mutation in marginal zone B-cell lymphoma

Author keywords

IgM paraprotein; lymphoplasmacytic lymphoma; marginal zone lymphoma; MYD88 L265P; plasmacytic differentiation; splenic marginal zone lymphoma

Indexed keywords

MYD88 PROTEIN, HUMAN; MYELOID DIFFERENTIATION FACTOR 88; TUMOR MARKER;

EID: 84928523511     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0000000000000411     Document Type: Article
Times cited : (80)

References (17)
  • 1
    • 40749143143 scopus 로고    scopus 로고
    • Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria
    • Matutes E, Oscier D, Montalban C, et al. Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria. Leukemia. 2008;22:487-495.
    • (2008) Leukemia. , vol.22 , pp. 487-495
    • Matutes, E.1    Oscier, D.2    Montalban, C.3
  • 2
    • 79961006284 scopus 로고    scopus 로고
    • Marginal zone lymphomas with plasmacytic differentiation and related disorders
    • Molina TJ, Lin P, Swerdlow SH, et al. Marginal zone lymphomas with plasmacytic differentiation and related disorders. Am J Clin Pathol. 2011;136:211-225.
    • (2011) Am J Clin Pathol. , vol.136 , pp. 211-225
    • Molina, T.J.1    Lin, P.2    Swerdlow, S.H.3
  • 4
    • 20444441543 scopus 로고    scopus 로고
    • Clinicopathologic features of Waldenstrom's macroglobulinemia and marginal zone lymphoma: Are they distinct or the same entity?
    • Berger F, Traverse-Glehen A, Felman P, et al. Clinicopathologic features of Waldenstrom's macroglobulinemia and marginal zone lymphoma: are they distinct or the same entity? Clin Lymphoma. 2005;5:220-224.
    • (2005) Clin Lymphoma. , vol.5 , pp. 220-224
    • Berger, F.1    Traverse-Glehen, A.2    Felman, P.3
  • 5
    • 79551686422 scopus 로고    scopus 로고
    • Oncogenically active MYD88 mutations in human lymphoma
    • Ngo VN, Young RM, Schmitz R, et al. Oncogenically active MYD88 mutations in human lymphoma. Nature. 2011;470:115-119.
    • (2011) Nature. , vol.470 , pp. 115-119
    • Ngo, V.N.1    Young, R.M.2    Schmitz, R.3
  • 6
    • 84877343691 scopus 로고    scopus 로고
    • MYD88 L265P in Waldenstrom macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction
    • Xu L, Hunter ZR, Yang G, et al. MYD88 L265P in Waldenstrom macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction. Blood. 2013;121:2051-2058.
    • (2013) Blood. , vol.121 , pp. 2051-2058
    • Xu, L.1    Hunter, Z.R.2    Yang, G.3
  • 7
    • 84865475885 scopus 로고    scopus 로고
    • MYD88 L265P somatic mutation in Waldenstrom's macroglobulinemia
    • Treon SP, Xu L, Yang G, et al. MYD88 L265P somatic mutation in Waldenstrom's macroglobulinemia. N Engl JMed. 2012;367:826-833.
    • (2012) N Engl JMed. , vol.367 , pp. 826-833
    • Treon, S.P.1    Xu, L.2    Yang, G.3
  • 8
    • 84879404052 scopus 로고    scopus 로고
    • MYD88 L265P mutation in Waldenstrom macroglobulinemia
    • Poulain S, Roumier C, Decambron A, et al. MYD88 L265P mutation in Waldenstrom macroglobulinemia. Blood. 2013;121:4504-4511.
    • (2013) Blood. , vol.121 , pp. 4504-4511
    • Poulain, S.1    Roumier, C.2    Decambron, A.3
  • 9
    • 84881482021 scopus 로고    scopus 로고
    • MYD88 L265P is a marker highly characteristic of, but not restricted to, Waldenstrom's macroglobulinemia
    • Jimenez C, Sebastian E, Chillon MC, et al. MYD88 L265P is a marker highly characteristic of, but not restricted to, Waldenstrom's macroglobulinemia. Leukemia. 2013;27:1722-1728.
    • (2013) Leukemia. , vol.27 , pp. 1722-1728
    • Jimenez, C.1    Sebastian, E.2    Chillon, M.C.3
  • 10
    • 84878423649 scopus 로고    scopus 로고
    • Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenstrom's macroglobulinemia and related lymphoid neoplasms
    • Varettoni M, Arcaini L, Zibellini S, et al. Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenstrom's macroglobulinemia and related lymphoid neoplasms. Blood. 2013;121:2522-2528.
    • (2013) Blood. , vol.121 , pp. 2522-2528
    • Varettoni, M.1    Arcaini, L.2    Zibellini, S.3
  • 11
    • 84887396799 scopus 로고    scopus 로고
    • MYD88 (L265P) mutation is an independent risk factor for progression in patients with IgM monoclonal gammopathy of undetermined significance
    • Varettoni M, Zibellini S, Arcaini L, et al. MYD88 (L265P) mutation is an independent risk factor for progression in patients with IgM monoclonal gammopathy of undetermined significance. Blood. 2013;122:2284-2285.
    • (2013) Blood. , vol.122 , pp. 2284-2285
    • Varettoni, M.1    Zibellini, S.2    Arcaini, L.3
  • 12
    • 13244253874 scopus 로고    scopus 로고
    • Lymphoid neoplasm associated with IgM paraprotein. A study of 382 patients
    • Lin P, Hao S, Handy BC, et al. Lymphoid neoplasm associated with IgM paraprotein. A study of 382 patients. Am J Clin Pathol. 2005;123:200-205.
    • (2005) Am J Clin Pathol. , vol.123 , pp. 200-205
    • Lin, P.1    Hao, S.2    Handy, B.C.3
  • 13
    • 0034208482 scopus 로고    scopus 로고
    • Clinicopathological correlates of IgM paraproteinemias
    • discussion 4-5
    • Owen RG, Parapia LA, Higginson J, et al. Clinicopathological correlates of IgM paraproteinemias. Clin Lymphoma. 2000;1:39-43; discussion 4-5.
    • (2000) Clin Lymphoma. , vol.1 , pp. 39-43
    • Owen, R.G.1    Parapia, L.A.2    Higginson, J.3
  • 14
    • 0023240678 scopus 로고
    • The spectrum of IgM monoclonal gammopathy in 430 cases
    • Kyle RA, Garton JP. The spectrum of IgM monoclonal gammopathy in 430 cases. Mayo Clin Proc. 1987;62:719-731.
    • (1987) Mayo Clin Proc. , vol.62 , pp. 719-731
    • Kyle, R.A.1    Garton, J.P.2
  • 15
    • 84873568405 scopus 로고    scopus 로고
    • IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenstrom macroglobulinemia/lymphoplasmacytic lymphomas
    • Gachard N, Parrens M, Soubeyran I, et al. IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenstrom macroglobulinemia/lymphoplasmacytic lymphomas. Leukemia. 2013;27:183-189.
    • (2013) Leukemia. , vol.27 , pp. 183-189
    • Gachard, N.1    Parrens, M.2    Soubeyran, I.3
  • 16
    • 84865167399 scopus 로고    scopus 로고
    • MYD88 somatic mutations in MALT lymphomas
    • Li ZM, Rinaldi A, Cavalli A, et al. MYD88 somatic mutations in MALT lymphomas. Br J Haematol. 2012;158:662-664.
    • (2012) Br J Haematol. , vol.158 , pp. 662-664
    • Li, Z.M.1    Rinaldi, A.2    Cavalli, A.3
  • 17
    • 85060361523 scopus 로고    scopus 로고
    • MYD88 mutation anlysis helps define nodal lymphoplasmacytic lymphoma
    • Epub ahead of print
    • Hamadeh F, MacNamara SP, Aguilera NS, et al. MYD88 mutation anlysis helps define nodal lymphoplasmacytic lymphoma. Mod Pathol. 2014. [Epub ahead of print].
    • (2014) Mod Pathol.
    • Hamadeh, F.1    Macnamara, S.P.2    Aguilera, N.S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.